Business / Finance

RSS

Gen-Probe board authorizes $150 million stock repurchase

Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.

16 Feb 2011

Orthofix 2010 net sales increase 3% to $564.4 million

Orthofix International N.V. today announced its results for the fourth quarter and year ended December 31, 2010.

16 Feb 2011

Benchmark signs definitive agreement to form $890 million partnership with Health Care REIT

Benchmark Senior Living, the leading provider of senior living services in the Northeast, announced today that it has signed a definitive agreement to form an $890 million partnership with Health Care REIT, Inc., an S&P 500 company that invests across the full spectrum of senior housing and health care real estate.

16 Feb 2011

UMB achieves 35% increase in health spending accounts

UMB Healthcare Services, a division of UMB Financial Corporation, announced today that it has achieved a 35 percent increase in the number of its health spending accounts.

15 Feb 2011

Prime Health Services acquires Applied Metrics

Prime Health Services, one of the nation's largest workers' compensation, group health, and first party auto liability PPO networks, is pleased to announce it has acquired majority interest in Applied Metrics.

15 Feb 2011

Cynosure 2010 fourth quarter revenues increase 16% to $22.3 million

Cynosure, Inc. today announced financial results for the three months and year ended December 31, 2010.

15 Feb 2011

China Jo-Jo Drugstores revenues increase 20.9% to $18.0 million

China Jo-Jo Drugstores, which operates retail pharmacies in the People's Republic of China, reported financial results for the third quarter and nine-month period of fiscal 2011 ended December 31, 2010.

15 Feb 2011

Apricus Bio awards Neopharm exclusive rights to market and sell Vitaros in Israel and Palestinian Territories

Apricus Biosciences, Inc., announced today that it has entered into a licensing agreement granting Neopharm Group the exclusive rights to market and sell Vitaros®, Apricus Bio's treatment for erectile dysfunction ("ED") and, when and if available, its formulation for the treatment of premature ejaculation ("PE"), in Israel and the Palestinian Territories of the Gaza Strip and the West Bank.

15 Feb 2011

Sonoma announces closing of $22 million Series D financing

Sonoma Orthopedic Products announced that it has closed a $22 million Series D financing round led by Ascension Health Ventures (AHV). Also participating in the round were Split Rock Partners, Legacy Life Sciences, EDF Ventures, MedVenture Associates, DFJ InCube Ventures, Emergent Medical Partners, and Asset Management Partners.

14 Feb 2011

Cantel Medical acquires ConFirm's sterilization monitoring business

CANTEL MEDICAL CORP., through its Crosstex International subsidiary, has further expanded its infection prevention and control business by purchasing the sterilization monitoring business of ConFirm Monitoring Systems, Inc. Based in Denver, Colorado, ConFirm is one of the leading providers of biological monitoring services in North America.

14 Feb 2011

Australian Department of Defence, CSC sign contract to develop, implement JeHDI system for ADF

In a press conference today with the Australian Department of Defence, CSC announced it has signed a five-year information technology contract to develop and implement an electronic health information system for the Australian Defence Force known as the Joint eHealth Data and Information system.

14 Feb 2011

Swisher Hygiene enters definitive agreement to acquire Choice Environmental Services

Swisher Hygiene Inc., a leading provider of essential hygiene and sanitation products and services, today announced that it has entered into a definitive agreement to acquire Choice Environmental Services, a Fort Lauderdale, Florida-based residential and commercial solid waste services company, by way of a statutory merger involving a wholly-owned subsidiary of Swisher Hygiene.

14 Feb 2011

bioMD makes offer for Allied Medical

bioMD Limited (ASX: BOD), a company with assets in regenerative tissue engineering technologies today announced that it has made an offer to buy all of the shares in Allied Medical Limited (Allied), a public unlisted company that specialises in the sales, distribution and commercialisation of medical technologies.

14 Feb 2011

Microbix first quarter revenues decrease 34% to $812,694

Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and livestock semen sexing, in addition to a core business of virology products, today reported financial results for the first quarter of fiscal 2011. For the quarter ended December 31, 2010, Microbix reported revenues of $812,694, a 34% decrease from $1,226,538 for the same period in 2009.

14 Feb 2011

K-V Pharmaceutical to raise $32 million through private placement

K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.

14 Feb 2011

Corgenix second quarter revenues decrease 8.9%

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, today filed its second quarter Form 10-Q and reported its financial results. The report disclosed that the company's revenues slightly declined during the quarter but were more than offset by decreases in operating expenses and interest expense, resulting in a smaller net loss for the period.

14 Feb 2011

Chimerix announces completion of $45 million Series F financing

Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F financing. New Leaf Venture Partners led the round, with participation by new investors Pappas Ventures and Morningside Group, as well as existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures.

14 Feb 2011

Cord Blood America purchases minority interest in Stem Cells VIDAPLUS

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that it has purchased a minority interest in Stem Cells VIDAPLUS, a Spanish-owned company which preserves umbilical cord stem cells at the Institute of Transfusion Medicine and Immunology of the Red Cross in Frankfurt, Germany.

14 Feb 2011

Tianyin Pharmaceutical's second quarter revenue increases 69.6% to $25.3 million

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the second quarter of Fiscal Year 2011.

14 Feb 2011

BioTime to merge Glycosan with OrthoCyte

BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it has signed a definitive agreement to merge Utah-based Glycosan BioSystems, Inc. (Glycosan) with BioTime's wholly-owned subsidiary, OrthoCyte Corporation. The acquisition is expected to close by March 18, 2011.

14 Feb 2011